5-(3-(4-(3-amino-3-(1-nitroacridin-2-yl)propyl)piperazin-1-yl)propylamino)-8-hydroxy-6H-imidazo[4,5,1-de]acridin-6-one

ID: ALA4784066

Chembl Id: CHEMBL4784066

PubChem CID: 162665631

Max Phase: Preclinical

Molecular Formula: C37H38N8O4

Molecular Weight: 658.76

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C1C2=C(NCCCN3CCN(CCCNc4c5ccccc5nc5cccc([N+](=O)[O-])c45)CC3)C=CC3N=CN(c4ccc(O)cc41)C23

Standard InChI:  InChI=1S/C37H38N8O4/c46-24-10-13-31-26(22-24)37(47)34-28(11-12-30-36(34)44(31)23-40-30)38-14-4-16-42-18-20-43(21-19-42)17-5-15-39-35-25-6-1-2-7-27(25)41-29-8-3-9-32(33(29)35)45(48)49/h1-3,6-13,22-23,30,36,38,46H,4-5,14-21H2,(H,39,41)

Standard InChI Key:  BAVAIUQLMOYYEV-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4784066

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 658.76

Molecular Weight (Monoisotopic): 658.3016

AlogP: 4.71

#Rotatable Bonds: 11

Polar Surface Area: 139.47

Molecular Species: NEUTRAL

HBA: 11

HBD: 3

#RO5 Violations: 2

HBA (Lipinski): 12

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 9.30

CX Basic pKa: 8.14

CX LogP: 2.92

CX LogD: 2.15

Aromatic Rings: 4

Heavy Atoms: 49

QED Weighted: 0.09

Np Likeness Score: -0.21

References

1. Paluszkiewicz E,Horowska B,Borowa-Mazgaj B,Peszyńska-Sularz G,Paradziej-Łukowicz J,Augustin E,Konopa J,Mazerska Z.  (2020)  Design, synthesis and high antitumor potential of new unsymmetrical bisacridine derivatives towards human solid tumors, specifically pancreatic cancers and their unique ability to stabilize DNA G-quadruplexes.,  204  [PMID:32736230] [10.1016/j.ejmech.2020.112599]

Source

Source(1):

• Scientific Literature